Macimorelin
Also known as: Macrilen, AEZS-130
Oral ghrelin mimetic used as a diagnostic agent for adult GH deficiency. Stimulates GH release via GHS-R1a.
- Typical dose
- 35 mg
- Frequency
- as needed
- Route
- Oral
- Half-life
- 4.1 hours
- Routes
- Oral
- Status
- FDA-approved (diagnostic)
Benefits
- GH stimulation test
- Diagnostic for GH deficiency
- Oral administration
Dosing
A common research range for Macimorelin is 35 mg as needed. These figures are reference points from published literature, not a prescription — your protocol should be set with a licensed provider.
Half-life
Macimorelin has an approximate half-life of 4.1 hours. Vial plots the real concentration curve from your logged doses so you can see peak windows and when levels taper.
Storage
Room temperature.
Reported side effects
- Dysgeusia
- Dizziness
- Headache
- Nausea
Contraindications
- QT-prolonging medications
Track Macimorelin with Vial
Vial logs every Macimorelin dose, plots its half-life curve, calculates reconstitution math, and keeps your whole protocol on schedule — on-device and private. Download Vial on the App Store →
This page is for educational and harm-reduction purposes only. Macimorelin is not FDA-approved for most uses described here. Always consult a licensed physician before starting any peptide protocol. Vial does not sell peptides, recommend vendors, or provide medical advice.